Cardiac syndrome X: Diagnosis, pathogenesis and management (multiple letters)

American Journal of Cardiovascular Drugs

Volumn 4, Issue 6, 2004, Pages 423-

  Dominguez Rodriguez, A ^a   Garcia Gonzalez, M ^a   Abreu Gonzalez, P ^b   Kaski, Juan Carlos ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; MELATONIN;

ADRENERGIC SYSTEM; ANGIOCARDIOGRAPHY; CIRCADIAN RHYTHM; HEART MUSCLE OXYGEN CONSUMPTION; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; LETTER; MICROANGIOPATHY; MOLECULAR MECHANICS; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SYNDROME X;

EID: 10444226484     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200404060-00010     Document Type: Letter

References (5)

1. 1. J.C. Kaski G. Aldama J. Cosín-Sales 2004 Cardiac syndrome X: diagnosis, pathogenesis and management Am J Cardiovasc Drugs 4 179 94 15134470 10.2165/00129784-200404030-00005 Kaski JC, Aldama G, Cosín-Sales J. Cardiac syndrome X: diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004; 4: 179–94
2. 2. G.A. Lanza A. Giordano C. Pristipino 1997 Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [ 123 I]metaiodo-benzylguanidine myocardial scintigraphy Circulation 96 821 6 9264488 10.1161/01.CIR.96.3.821 1:STN:280:DyaK2svgslOguw%3D%3D Lanza GA, Giordano A, Pristipino C, et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [ 123 I]metaiodo-benzylguanidine myocardial scintigraphy. Circulation 1997; 96: 821–6
3. 3. R.J. Reiter 1991 Pineal melatonin: cell biology of its synthesis and of its physiological interactions Endocrinol Rev 12 151 80 10.1210/edrv-12-2-151 1:CAS:528:DyaK3MXlsFSlsLs%3D Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrinol Rev 1991; 12: 151–80
4. 4. A. Altun M. Yaprak M. Aktoz 2002 Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X Neurosci Lett 327 143 5 12098655 10.1016/S0304-3940(02)00368-3 1:CAS:528:DC%2BD38XkvFyrsLg%3D Altun A, Yaprak M, Aktoz M, et al. Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci Lett 2002; 327: 143–5
5. 5. A. Dominguez-Rodriguez P. Abreu-Gonzalez M.J. Garcia 2002 Decreased nocturnal melatonin levels during acute myocardial infarction J Pineal Res 33 248 52 12390508 10.1034/j.1600-079X.2002.02938.x 1:CAS:528:DC%2BD38XosFyrt7o%3D Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia MJ, et al. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002; 33: 248–52